» Articles » PMID: 2866634

Disposition of the Psychotropic Drugs Buspirone, MJ-13805 and Piribedil, and of Their Common Active Metabolite 1-(2-pyrimidinyl)-piperazine in the Rat

Overview
Journal Xenobiotica
Publisher Informa Healthcare
Specialties Biochemistry
Toxicology
Date 1985 Oct 1
PMID 2866634
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

1-(2-Pyrimidinyl)-piperazine (PmP) is a common metabolite of the structurally related drugs buspirone, MJ-13805 and piribedil. After i.v. injection (25 mumol/kg) to rats, all three parent drugs are rapidly cleared with a t 1/2 (beta) of about 30 min. The metabolite t 1/2 is about four times that of its parent drugs. About 25, 23 and 2% of buspirone, MJ-13805 and piribedil, respectively, reaches the systemic circulation as PmP. The metabolite concentrates in the brain where its A.U.C. is about twice those of buspirone and MJ-13805. Results indicate that PmP formation is a pharmacologically significant process for both buspirone and MJ-13805 but it is probably less important for piribedil.

Citing Articles

Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.

Caccia S, Vigano G, Mingardi G, Garattini S, Gammans R, Placchi M Clin Pharmacokinet. 1988; 14(3):171-7.

PMID: 3370902 DOI: 10.2165/00003088-198814030-00005.


Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.

Goa K, Ward A Drugs. 1986; 32(2):114-29.

PMID: 2874976 DOI: 10.2165/00003495-198632020-00002.


Mode of action of tiaspirone on the central cholinergic system.

Kolasa K, Palazzi E, Salmoiraghi P, Guiso G, Caccia S, Garattini S Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(3):259-64.

PMID: 2572973 DOI: 10.1007/BF00168507.


A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade.

Engberg G J Neural Transm. 1989; 76(2):91-8.

PMID: 2565361 DOI: 10.1007/BF01578749.


Kinetics of piribedil and effects on dopamine metabolism: hepatic biotransformation is not a determinant of its dopaminergic action in rats.

Sarati S, Guiso G, Garattini S, Caccia S Psychopharmacology (Berl). 1991; 105(4):541-5.

PMID: 1771223 DOI: 10.1007/BF02244377.